Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Fc-optimized NKG2D-Fc constructs induce NK cell antibody-dependent cellular cytotoxicity against breast cancer cells independently of HER2/neu expression statusStefanie Raab, Julia Steinbacher, Benjamin J Schmiedel, et al.BMC Cancer|May 3, 2015
Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroidsAriane Giannattasio, Sandra Weil, Stephan Kloess, et al.Frontiers in Immunology|March 23, 2017
The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector CellsKyra Fischer, Sara Tognarelli, Stefanie Roesler, et al.European Journal of Immunology|February 21, 2003
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoproteinStefan A Welte, Christian Sinzger, Stefan Z Lutz, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICAMercedes Kloss, Patrice Decker, Katrin M Baltz, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Altered microRNA expression after infection with human cytomegalovirus leads to TIMP3 downregulation and increased shedding of metalloprotease substrates, including MICAGloria Esteso, Elisa Luzón, Elisabeth Sarmiento, et al.Medical Microbiology and Immunology|August 8, 2008
Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cellsKai-Fu Tang, Min Chen, Jing Xie, et al.Frontiers in Immunology|May 20, 2021
Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus ErythematosusBaptiste Hervier, Matthieu Ribon, Nadine Tarantino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinomaSorin Armeanu, Matthias Krusch, Katrin M Baltz, et al.International Journal of Cancer|July 22, 2014
An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemiaJulia Steinbacher, Katrin Baltz-Ghahremanpour, Benjamin Joachim Schmiedel, et al.Pageof 9